A Safety Evaluation Trial of TEV-48125 Self-administered in Migraine Patients
Clinical trial NCT04355117 · COMPLETED
Trial details
- NCT number
- NCT04355117
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-17
- Primary completion
- 2020-11-11
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.